Download Adult Peripheral Intravenous Cannula Insertion and

Policy Compliance Procedure
Document Metadata
Title
Adult Peripheral Intravenous Cannula Insertion and Management
Date Created
1 Aug 2007
Date Modified
Sept 2014
Next Review Date
Sept 2016
Description
To provide Western Sydney Local Health District staff with a framework for the safe insertion, management and
removal of peripheral intravenous cannula (PIVC) in adult patients, to minimise health-care associated infection
(HAI) risks. This document will also provide directions for staff in the identification and management of a PIVC
infection
Source
GL2013_013
Key words
Cannulation; PIVC; Peripheral Cannulation; IV Cannula Insertion
Principal Author
Kathy DEMPSEY, Jo TALLON
CNCs / Co Managers Infection Prevention & Control
[email protected] ; [email protected]
9845 7501
Infection Prevention & Control
Contributors
Lyn Gilbert, Vascular Access working party, WSLHD Infection Control Committee
Versioning
Does this replace a
resource that already
exists in the Policy
and Procedure
Document Database

Facility
Select the facility/s
that this document
applies to

Yes
No
If yes, name Document:
Adult Peripheral Intravenous Cannula Insertion and Management
PROC20137
Version 9.0
WSLHD
Westmead Hospital
Auburn Hospital
Cumberland Hospital
BMDH
Community Health Services
Western Sydney Local Health District
Page 1 of 16
Draft
WSLHD Policy Compliance Procedure Title
DRAFT
(authorised final version to be downloaded
from website)
Adult Peripheral Intravenous Cannula
Insertion and Management
Date Created:
August 2007
Last Updated:
Feb 2012
Review Date:
24th September 2014
Version:
9
Drug Committee Approved:
Western Sydney Local Health District
Page 2 of 16
Draft
WSLHD Policy Compliance Procedure Title
Policy Compliance Procedure Statement
All clinical staff must ensure that the insertion, management and removal of all peripheral
intravenous cannula in adult patients is consistent with NSW Health Department Infection
Control Policy (PD 2007_036), Guideline for Peripheral Intravenous Cannula (PIVC)
Insertion And Post Insertion Care In Adult Patients (GL2013_013 and Australian Guidelines
for the Prevention and Control of Infection in Healthcare (2010).
Purpose
To provide Western Sydney Local Health District staff with a framework for the safe
insertion, management and removal of peripheral intravenous cannula in adult patients, to
minimise health-care associated infection (HAI) risks. Also to provide directions for staff in
the identification and management of a PIVC infection.
Intended Audience
This document is a standard procedure for all clinical staff involved in the management and
insertion of peripheral intravenous cannula in the Western Sydney Local Health District.
Staff must have attended and completed the requirements of the peripheral IV cannulation
workshop PRIOR to any IV cannulation attempts
Expected Outcomes






The potential for infection from a PIVC is minimised
Aseptic technique is used during each PIVC insertion and access to reduce the risk of
local or systemic infection.
Every PIVC insertion is documented at the time of insertion or as soon as possible
afterwards.
The insertion of a PIVC will occur in a safe and timely manner by a competent and
appropriately trained health care worker.
All PIVC are inserted with minimal discomfort to patient and patent venous access is
obtained.
Appropriate and early identification and management of PIVC infection
Definitions
Alcohol-based hand
rub (ABHR)
An alcohol-containing preparation designed for application to the
hands in order to reduce the number of viable micro-organisms
with maximum efficacy and speed1
Asepsis
‘Freedom from infection or infectious (pathogenic) material’.
Western Sydney Local Health District
Page 3 of 16
Draft
WSLHD Policy Compliance Procedure Title
Antiseptics
Antimicrobial substances that are applied to the skin to reduce
the number of micro-organisms. Examples include topical
alcohols, chlorhexidine, triclosan and iodine2
Aseptic technique
An aseptic technique aims to prevent microorganisms on hands,
surfaces and equipment from being introduced to susceptible
sites3
Bloodstream
infections (BSIs)
The presence of live pathogen(s) in the blood, causing an
infection3
Decontaminate
Use of physical or chemical means to remove, inactivate, or
destroy pathogens on a surface or item so that they are no
longer capable of transmitting infectious particles and the surface
or item is rendered safe for handling, use, or disposal3
Healthcare associated
infection (HAI)
Infection acquired in a healthcare facility or an infection that
occurs as a result of a healthcare intervention and which may
manifest after the patient is discharged from the healthcare
facility3
IIMS
Intravascular device
(IVD)
Must
Incident Information Management System5
A catheter inserted into a blood vessel, more commonly a
peripheral vein (e.g. small veins in the arms).
Indicates mandatory action
Peripheral Intravenous
Cannula PIVC
For the purpose of this Policy a device that is designed to be
inserted into and remain within a peripheral vein (excludes
peripherally inserted central line catheters)
Should
Indicates a recommended action that should be followed unless
there are sound reasons for taking a different course of action6
1. Requirement for a peripheral Intravenous Cannula
1.1 PIVC Insertion Requirement
Only competent/trained clinicians or clinicians under direct supervision of an experienced
Clinician should insert a PIVC.
Western Sydney Local Health District
Page 4 of 16
Draft
WSLHD Policy Compliance Procedure Title
1.2 Other factors to consider
1.2.1 Consult the relevant Medical Officer before insertion to ensure that
 A PIVC is required
 Alternatives have been considered
 The benefits outweigh the risks.
1.2.2 Remove PIVCs as soon as they are no longer clinically required7,8.
1.2.3 Trained clinicians should keep written evidence of training and competence so that it
can be produced when transferring to other health services.
1.2.4 Clinicians should only have 2 attempts at insertion, if unsuccessful the next
experienced clinician within the team or the anaesthetist must be called.
1.2.5 PIVCs should not routinely remain in situ for longer than 72 hours7,8,14. The responsible
Medical Officer should review the PIVC prior to 72 hours after insertion to determine whether
it should be removed or replaced. The PIVC should be removed if there are signs of local
infection or thrombosis.
A PIVC may be retained beyond 72 hours, if there are no signs of inflammation and:
 Replacement is likely to be difficult and the risk is judged to be greater
than retention
 The PIVC is likely to be needed for another 24 hours or less.
 The decision should be document in the patient’s health record.
1.2.6 When repeated or prolonged administration of chemical irritants, such as potassium
chloride or vancomycin, is required, central venous access should be considered, to avoid
peripheral vein damage7,8.
1.2.7 In-line filters are ineffective and not recommended to reduce the risk of infection8.
1.2.8 Only “capless” injection sites should be used on PIVCs. Ideally these should be of the
split septum type.
2. Procedure
2.1 Indications for insertion of peripheral intravenous cannula
•
•
•
•
•
Resuscitation of the patient.
Volume & Electrolyte Replacement
Blood / blood product administration
Administration of Parenteral Drugs.
Maintenance of Venous Access
Western Sydney Local Health District
Page 5 of 16
Draft
WSLHD Policy Compliance Procedure Title
2.3 Equipment
•
•
•
•
•
•
•
•
•
•
•
•
Intravenous Trolley (if available)
IV Starter Pack with Tourniquet
Approved skin alcohol- based chlorhexidine swab (greater 0.5 % chlorhexidine gluconate
in 70% isopropyl alcohol) stick swab.
Appropriate size intravenous safety cannula.
Kidney Dish (non sterile)
Cannula cap / reflux valve.
Semi-permeable occlusive dressing (transparent)
Normal saline flush 10mLs and syringe.
Protective blue sheet.
Sterile Gloves.
Sharps container.
Cannula sticker.
2.4 Preparation
•
•
•
•
•
•
•
•
Correctly identify the patient.
Explain procedure and obtain patient’s verbal consent
Check allergy status of the patient
Assemble and prepare all equipment required using aseptic technique
Place sodium chloride ampoule under opened IV starter pack ready to be drawn up with
blunt drawing up needle, once clinician has put on sterile gloves
Select the appropriate vein.
Avoid the use of veins in the following sites, if possible11;
 Areas of flexion, e.g. antecubital fossa, or bony prominences
 Uncomfortable as this requires splinting
 Vein easily damaged
 Risk of thrombosis. Infiltration, dislodgement & interruption
of flow
 Areas below previous cannulation site
 Vein may be damaged
 Bruised or phlebitic areas
 Poor venous return
Pieces of clot can be dislodged into the system
 A limb with an arteriovenous fistulae or shunt (the cephalic vein should not be
used in patients with impaired renal function)
 May compromise haemodialysis access
 An arm on the same side as a previous lymph node dissection, mastectomy
or affected by cerebrovascular accident
 Poor venous and/or lymphatic return
 An infected limb e.g. with cellulitis
 A limb with a peripherally inserted central catheter (PICC) or implanted
venous access device (port-a-cath)
 Lower limbs
 Risk of deep vein thrombosis
 Limits access, patient comfort and mobility.
Position the patient in a comfortable position in which the position of the arm promotes
venous engorgement.
Clip hair only if necessary. (Note: shaving is not recommended).
Western Sydney Local Health District
Page 6 of 16
Draft
WSLHD Policy Compliance Procedure Title
2.5 Skin Preparation
•
•
•
•
•
Wash Hands with antimicrobial hand wash prior to skin preparation or perform HH with
ABHR
Before device insertion, the site must be decontaminated using a single-use application
of alcohol-based chlorhexidine gluconate swab (greater than 0.5 % chlorhexidine
gluconate in 70% isopropyl alcohol). Apply antiseptic using a circular motion from inside
to outside and allow skin to dry for 2 minutes.
If insertion through or close to mucous membranes is necessary, use aqueous swab
supplemented with 2% chlorhexidine.
For patients with a history of chlorhexidine sensitivity, use 5% alcohol-based povidoneiodine swab or 10% aqueous povidone-iodine, or 70% alcohol swab if insertion is
through or close to mucous membranes insertion.
Apply Tourniquet
2.5 Cannula Insertion
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Wash hands with antimicrobial chlorhexidine hand wash for sixty seconds and then dry
hands with sterile hand towel or perform HH with ABHR for a minimum 30 seconds as
per NSW Health Hand Hygiene Policy 2010_058
Don Sterile gloves
Maintain gentle opposing traction on skin below cannula insertion site.
Puncture skin with cannula at 15-30º angle depending on site chosen.
Upon flashback visualisation, decrease the cannula to skin angle.
Continue to insert cannula in accordance to manufacturer’s instructions.
Remove stylet and place in sharps container.
Attach cannula cap and anchor cannula securely with steri-strips (if required) and the
transparent cannula dressing.
Release tourniquet
Flush cannula with 10mls normal saline using blunt drawing up needle.
Ensure there is no evidence of swelling, haematoma, fluid leakage at the cannula site.
Dispose of equipment, remove gloves and attend hand hygiene.
Document date and time of insertion using cannula placement sticker.
Apply the narrow strip section of the cannula insertion sticker to the transparent dressing
ensuring it is NOT covering the peripheral cannula insertion site.
The remaining section of the cannulation placement sticker is to be included in the
patient’s medical record and include the date/ time inserted and the size and gauge of
cannula inserted.
Important note: Assistance is to be sought if unable to insert a cannula after no more
than two (2) attempts in a non emergency situation.
Each attempt requires a new set up
2.6 Aseptic Technique
2.7
Touching the insertion site, the shaft or tip of the PIVC or other sterile equipment breaches
aseptic technique3,7. To follow aseptic technique, clinicians should avoid touching:
 The insertion site after decontamination
 Sterile parts of the PIVC (i.e. shaft and tip)
 Other sterile equipment.
The wearing of sterile gloves facilitates compliance with asepsis especially where palpation
of the direct insertion site is required after decontamination3.
Western Sydney Local Health District
Page 7 of 16
Draft
WSLHD Policy Compliance Procedure Title
3. Maintenance, Care and Routine Assessment
•
•
•
•
•
•
•
•


•
All peripheral intravenous cannula are to be assessed each shift for patency and
clinical signs of infection such as swelling, inflammation, discharge, redness or pain. If
the cannula is not patent or clinical signs of infection are present remove the cannula
and notify the appropriate Medical Officer.
The use of a Visual Infusion Phlebitis (VIP) score would be a recommended assessment.
Please refer to education notes for this method of assessment.
If a cannula is inserted in a medical emergency situation prior to hospital admission,
remove as soon as possible or within 24 hours inserting a new device under appropriate
aseptic conditions.
All peripheral intravenous cannula are to be removed 72 hours after their insertion. If the
peripheral cannula is still required then replacement in a different site must be attended.
PIVC should be removed as soon as it is no longer needed
Assessment and selection of an appropriate alternate intravenous access device must
be considered for access required greater than 7days.
Intravenous giving sets must not be disconnected from the PIVC for general nursing
cares or any other reason.
If the PIVC and giving set become disconnected the giving set must be changed
Administration sets including all intravenous lines & connections and bungs must be
changed when the cannula is resited
Administration sets must be changed after blood products or lipids
All add on lines must be made through injection ports that have been decontaminated
just before attachment with chlorhexidine/alcohol swab & allowed to dry
3.1 Dressings
•
•
•
•
Use hand antisepsis and aseptic technique for any site care of any peripheral
intravenous cannula.
Use a sterile, transparent, semi-permeable dressing to cover the cannula site, ensure the
entry site can be seen for regular inspection.
If the patient is diaphoretic, or if the site is bleeding or oozing, a daily sterile gauze
dressing may be used.
Examine short-term peripheral intravenous cannula dressings at least once per shift and
change if the dressing is soiled or loose.
3.2 Patient Education
•
•
•
Educate the patient to be aware of the precautions that are required to avoid
complications with a peripheral intravenous cannula site. The patient should be
instructed to keep the site dry and minimise excessive movement whist the cannula is
insitu.
Advise patient to not touch the insertion site or dressing and to avoid touching the roller
clamp or infusion pump where used.
Encourage patient to notify staff if pain, swelling or redness are observed or
experienced.
3.3 Flushing PIVCs
PIVCs should have a continuous flow of IV fluids through them8.
Western Sydney Local Health District
Page 8 of 16
Draft
WSLHD Policy Compliance Procedure Title
Where a continuous flow is not possible then the PIVC should be flushed:
 After the PIVC is inserted to confirm correct placement
 Before each medication/infusion is given (to ensure the PIVC is still
patent)
 In between serial/multiple infusions and between medications to
prevent interactions and incompatibilities
 After each injection/infusion (to remove irritant material from the vein)
 After blood sampling (to clear the cannula of blood)
 For inpatients, at least every 8 hours if not otherwise used (note:
consider if the PIVC needs to stay in).
3.4 Blood collection via the PIVC
Blood may be drawn from a PIVC directly after insertion, but not at other times unless the
PIVC has been inserted for the purpose of blood collection.
3.6.5 Documentation

•
•
•
4.
Clear documentation of site/ cannula size/ date /time must be placed in patients
notes & sticker attached to exit dressing taking care not to cover the insertion site
Documentation of the assessment attended on each shift is to be recorded in the
patient’s medical record and on the patient safety handover checklist; use of resources
such as the VIP score is recommended..
If any signs or symptoms of infection are noted with peripheral intravenous cannula sites
they are to be recorded in the patient’s medical record and a report entered into the
Incident Information Management System (IIMS).
All bacteremias associated with the peripheral intravenous cannula will be rated as a
SAC 2 in IIMS by the notifier. The treating Medical Officer and Infection Control
Practitioner are to be notified and same documented in patient’s medical record.
Removal of the PIVC
Perform hand hygiene and don non-sterile gloves and protective eyewear.
1. Remove the dressing. Clean thoroughly with ≥70% alcohol and allow to dry.
Withdraw the cannula and apply digital pressure with sterile gauze until haemostasis
is achieved.
2. Inspect the PIVC to ensure the whole device was removed and none has been
retained in the patient.
3. Cover the site with a dressing. Sterile gauze can be used under the dressing if
bleeding or discharge continues. Remove the dressing after 24 hours or, if the patient
is discharged sooner, instruct the patient to remove the dressing.
4. Observe the PIVC site for 48 hours after removal to detect post-infusion phlebitis. If
the patient is discharged within that period advise the patient who to contact if pain,
swelling, discharge or bleeding at the site or systemic symptoms of infection develop.
5. Routine culturing of PIVC tips is not recommended unless infection is suspected.
6. Advise the patient to notify staff if any swelling or discharge occurs at the insertion
site after the PIVC is removed.
7. Document removal in the patients’ health record including the time and date; if the
PIVC was intact, whole and include the tip; and the condition of the site post removal.
Western Sydney Local Health District
Page 9 of 16
Draft
WSLHD Policy Compliance Procedure Title
5. Complications and Management
Complication
Cause
Action
Blocked or extravasated PIVC
Clot(s) in valve or PIVC
Remove PIVC.
Blood under transparent
occlusive dressing
Insertion trauma or skin
tears
Bruising – blue to black skin
discoloration around the PIVC
site
Extravasation of blood
into surrounding tissue.
 Check whether the PIVC has
tissued; if so remove it.
 Inform MO
Erythema – redness of the skin
surrounding the PIVC site
Tip - erythema disappears on
finger pressure.
Can be caused by
infection, inflammation or
injury.
 Check PIVC is patent,
continue therapy but check
PIVC every 4hours.
 Check with patient whether
there is any pain.
 Review if IV medication
therapy is still required; and if
so, if routeis appropriate.
Extravasated PIVC - swelling of
tissue proximal to the end of the
PIVC
IV fluid infiltration in
surrounding tissue.
 Stop infusion immediately,
remove PIVC, elevate limb.
 Inform MO.
Infusion not running
IV solution has run out.
Check IV solution
Volumetric pump has
failed or volume limit
reached.
Check volumetric pump
Volumetric pump set
removed from pump
(automatic off).
Put set back into volumetric
pump.
Roller clamp closed on
infusion line.
Check all roller clamps
Kinked IV tubing.
Check IV tubing is secured and
without kinks.
Patient position – PIVC
occluding against venous
valve in current patient
position.
Check patient position and
reposition arm.
Clot in capless valve.
Clot in PIVC.
Insertion site infection – pus
noted at the insertion site. Site is
swollen, inflamed, red and warm
to touch. Patient may be febrile.
Western Sydney Local Health District
Bacterial infection
 Remove dressing to check
cause of bleeding.
 Reapply dressing aseptically.
 Change split septum capless
valve and attempt to flush.
 Do not force flush if
resistance felt.
Remove PIVC.
 Stop infusion immediately,
remove PIVC, elevate limb.
 Inform MO.
 Document in IIMS (SAC 2).
Page 10 of 16
Draft
WSLHD Policy Compliance Procedure Title
Complication
Cause
Leaking PIVC
Loose connections
between PIVC and
administration sets or
capless valve.
Device not secured
properly and causing
irritation against the vein
wall.
Patient complaining of pain/
burning at PIVC site
Early signs of infection.
Action
 Check all connections are
secure.
 Flush with 10mL 0.9% saline
and observe for site of leak.
 Change lines/connections
 Check PIVC and tubing are
securely attached to patient.
 Check that what is being
administered is sufficiently
diluted.
 Check if the cannula is
extravasated.
 Inspect for signs of local
infection; remove PIVC if
present.
 Inform MO.
Risk Rating
Identification of the following risks has lead to this document being given a high risk rating:
 The potential to cause death of a patient as a result of infection from a peripheral
intravenous cannula site.
 The potential for increased length of stay for the patient along with the requirement of
additional treatment and procedures.
 The potential cost impact of infection causing an increased length of stay, additional
procedures and treatments.
Risk category(s):
Clinical Care & Patient Safety
Risk rating:
Medium - Review in 2 Years
Implementation Plan
All policies are to include an implementation plan suitable to support the appropriate
embedding of the policy into practice. The plans are to include: timeframe; communication
strategy; education strategy; resources required; and system for monitoring compliance.
Implementation Timeframe
Existing Policy in place
Position Responsible
Names of Persons Responsible
Brief
description
of Description of Implementation Strategy
implementation strategy:
Process for monitoring and Review of IIMs
review:
Management of SABSI by Infection Prevention & Control and
Patient Safety and Quality
Western Sydney Local Health District
Page 11 of 16
Draft
WSLHD Policy Compliance Procedure Title
Educational Notes
In order of effectiveness the following lists skin antisepsis that should be considered for use
for insertion of PIVC and provides the rational for product choice within this document:
1. Chlorhexidine 2% in ≥70% alcohol (swab twice and wait at least 1 minute before insertion)
where available (unless contraindicated, e.g. flammability issues or where the PIVC is
inserted in Day Only or Extended Day Only patients).
2. Chlorhexidine 0.5-1% in ≥70% alcohol may also be used.
3. Chlorhexidine 2% in water (allow to air dry before beginning insertion). 1% aqueous
chlorhexidine may also be used.
4. Povidone Iodine 10% in ≥70% alcohol (allow to air dry before beginning insertion).
5. Povidone Iodine 10% in water (allow to air dry before beginning insertion).
6. ≥70% alcohol (swab twice and wait at one minute before insertion) (note: should be used
where the PIVC is inserted in Day Only or Extended Day Only patients)
Notes 3,7,15:
 For a cannula that is likely to be in for <24 hours, skin cleaning with at least 70% alcohol
is sufficient
 For all other cannulae for recommended skin preparation is with alcoholic (70%)
chlorhexidine (>0.5%) or if there is hypersensitivity to chlorhexidine, either alcohol as
above or alcoholic povidone.
Visual Infusion Phlebitis Score
Phlebitis should be documented using a uniform standard scale for measuring degrees or
severity of phlebitis1. The VIP score was developed to reduce the incidence and impact of
infusion phlebitis. Infusion phlebitis originates from two main sources. One is mechanical the
other is chemical. By far the most prevalent cause of infusion phlebitis is chemical in origin.
Early recognition of phlebitis will help to maintain patient safety and comfort. Consideration
of blood flow past the tip of the catheter must be viewed in association with the chemical
composition of the drug to be infused. A pH between 5 and 9 is considered appropriate for
safe peripheral administration. However, Stranz and Kastango (2002) describe how a
phlebitic episode depends upon the type of tissue that the drug is coming into contact with.
They further describe “In vitro experiments have demonstrated that solution pH values of 2.3
and 11 kill venous endothelium cells on contact”.
VIP score now recommended in the Infusion Nursing Standards of Practice (INS 2011). “The
Visual Infusion Phlebitis (VIP) scale has content validity, inter-rater reliability, and is clinically
feasible. This scale includes suggested actions matched to each scale score”1.
The following provides the VIP score guide for staff to direct clinical management of the
PIVC.
1
INS (2011) Infusion Nursing Standards of Practice. Journal of Infusion Nursing. Supplement. 34(1s).
Western Sydney Local Health District
Page 12 of 16
Draft
WSLHD Policy Compliance Procedure Title
Notify Team
Consider ID Consult
Notify Team
Notify Team
Consider ID Consult
Notify Team
Consider ID Consult
Adapted from VIP score 1, 2, 3
References and Related Documents
1 Hand Hygiene Australia, 5 Moments for Hand Hygiene, July 2009 (Amended November
2009).
www.hha.org.au/UserFiles/file/Manual/ManualJuly2009v2(Nov09).pdf
2 Centers for Disease Control and Prevention. Guideline for Hand Hygiene in Health-Care
Settings: Recommendations of the Healthcare Infection Control Practices Advisory
Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR
2002;51(No. RR-16):[inclusive page numbers] http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
3 NHMRC (2010) Australian Guidelines for the Prevention and Control of Infection in
Healthcare.Commonwealth of Australia
http://www.nhmrc.gov.au/publications/synopses/cd33syn.htm
4 NSW Health Central Venous Access Device Insertion and Post Insertion Care
PD2011_060 http://www.health.nsw.gov.au/policies/pd/2011/pdf/PD2011_060.pdf
5 NSW Health Incident Management PD 2007_061
http://www.health.nsw.gov.au/policies/pd/2007/PD2007_061.html
1
INS (2011) Infusion Nursing Standards of Practice. Journal of Infusion Nursing. Supplement. 34(1s).
2
Gallant P and Schultz AA (2006) Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of
peripheral intravenous catheters. Journal of Infusion Nursing. vol. 29, no. 6, p. 338-45.
3
Stranz, M. and Kastango, E.S. (2002) A review of pH and osmolarity. International Journal of Pharmaceutical Compounding.
6(3), p.216-220.
Western Sydney Local Health District
Page 13 of 16
Draft
WSLHD Policy Compliance Procedure Title
6 NSW Health, Policy Distribution System (PDS) for NSW Health, PD2009_029.
http://www.health.nsw.gov.au/policies/pd/2009/PD2009_029.html
7 Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular
Catheter- Related Infections. 2011 http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines2011.pdf (accessed 18 September 2012)
8 Queensland Health Guideline Peripheral Intravenous Catheter Version 2, March 2013
http://www.health.qld.gov.au/qhpolicy/docs/gdl/qh-gdl-321-6-5.pdf
9 Langham BT, Harrison DA. Local anaesthetic: does it really reduce the pain of insertion of
all sizes of venous cannula? Anaesthesia, 1992, Volume 47, pages 890-891
10 Harris T, Cameron P A, Ugoni A. The use of pre-cannulation local anaesthetic and factors
affecting pain perception in the emergency department setting. Emerg Med J 2001;18:175–
177
11 Victorian Government Clinical Skills in Hospital Project, Intravenous Therapy, 2008
http://docs.health.vic.gov.au/docs/doc/3A3332AD97ECC38ACA25793600016ADD/$FILE/IV
_therapy2.pdf
(accessed 18 September 2012)
12 Australian and New Zealand Society of Blood Transfusions Ldt & Royal College of
Nursing Australia Guidelines for the Administration Of Blood Products, 2nd Edition
November 2011
http://www.anzsbt.org.au/publications/documents/ANZSBT_Guidelines_Administration_Bloo
d_Products_2ndEd_Dec_2011_Plain_Tables.pdf (accessed 4 January 2013)
13 NSW Health, User applied Labelling of Injectable Medicines, Fluids and Lines,
PD2012_007
http://www0.health.nsw.gov.au/policies/pd/2012/pdf/PD2012_007.pdf
14 Rickard, C.M., Webster, J., Wallis M.C., et al (2012) Routine versus clinically indicated
replacement of peripheral intravenous catheters: a randomised controlled equivalence trial,
The Lancet, Vol 380 pp. 1066-1074
15 Darouiche, R.O. and Mosier, M.C., (2010) Chlorhexidine-Alcohol versus Povidone-Idoine
for surgical site antisepsis. New England Journal of Medicine, 362(1) pp 18-26
16 Gallant, P. and Schultz, A.A., (2006) Evaluation of a Visual Infusion Phlebitis Scale for
Determining Appropriate Discontinuation of Peripheral Intravenous Catheters. Journal of
Infusion Nursing, 29(6) pp 338-345
Associated Documents
NSW Health Infection Control Policy (PD2007_036)
NSW Health Infection Control Policy: Prevention & Management of Multi-Resistant
Organisms (MRO) (PD 2007_084)
NSW Health Recognition and Management of Patients who are Clinically Deteriorating
(PD2011_077)
Western Sydney Local Health District
Page 14 of 16
Draft
WSLHD Policy Compliance Procedure Title
NSW Health Hand Hygiene Policy (PD2010_058)
NSW Health Central Venous Access Device Insertion and Post Insertion Care
(PD2011_060)
NSW Health User applied labelling of Injectable Medicines, Fluids and Lines (PD2012_007)
Version History
Date
24th Sept
2014
Version
9
Change details
Additions based on NSW Ministry of Health
Guidelines
Distributed to :WSLHD Infection Control Committee
WSLHD ICPs
Vascular Access
Author
Kathy
Dempsey
Date of Issue
Document Version Change Details
Author
Aug 2007
Version 1
D Scott, CNS
June 2010
Version 2
Reviewed
Lee-Ann Hurst, CNE
Chris Nicoll, ADON
Dec 2010
Version 3
Reviewed
L Hurst / E Soper
April 2011
May 2011
Version 4/5
Reviewed and merging
of work carried out by
AICC
Elisa Southall, Nurse
Manager
Michelle Roebuck, CNS
Kathy Dempsey, CNC
Jo Tallon, CNC
Robert Robinson, CNS
Lindy Ryan, CNC
June 2011
Version 6
Review
Kathy Dempsey, CNC
Jo Tallon, CNC
James Branley
Prof Lyn Gilbert
Lindy Ryan CNC
Elisa Southall, DDON
July 2011
Version 7
Re-formatted
Elaine Buggy
Chris Nicoll
July – Oct 2011
Version 7
Consultation with
Vascular Access
working party WSLHD Westmead
Kathy Dempsey
Jo Tallon
Vascular Access
working party members
November 2011
Version 8
Awaiting approval by
GM
Dan West
Kathy Dempsey
Jo Tallon
Western Sydney Local Health District
Page 15 of 16
Draft
WSLHD Policy Compliance Procedure Title
Date of Issue
Document Version Change Details
Author
Feb 2012
Version 8
Dan West
Kathy Dempsey
Jo Tallon
Western Sydney Local Health District
Approved by GM
Page 16 of 16